Evidence map›Paper›PMID 29743797›Full record

ArticleJournal of clinical and experimental hepatology2018

Natural History of Cirrhosis of Liver after First Decompensation: A Prospective Study in India.

Apurva S Shah, Deepak N Amarapurkar

Open access · bronzeAbstract read
In one paragraph

Article in Journal of clinical and experimental hepatology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 26 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Apurva S ShahDepartment of Gastroenterology, Apollo Hospital International Limited, Ahmedabad, India.
Deepak N AmarapurkarDepartment of Gastroenterology, Bombay Hospital & Medical Research Center, Mumbai, India.
Apollo Hospitals · INBombay Hospital · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

aimsAs liver cirrhosis is a dynamic condition, it is possible to improve survival in decompensated cirrhosis. Hence, we planned a prospective study to determine the natural history of cirrhosis after first decompensation.

methodsWe enrolled all patients of liver cirrhosis who presented with first episode of decompensation defined by the presence of ascites, either overt or detected by Ultrasonography (UD), Gastroesophageal Variceal Bleeding (GEVB), and Hepatic Encephalopathy (HE). All patients were followed up to death/liver transplant or at least for the period of 1 year. Multivariable Cox proportional hazards regression was used to analyze the risk of failure (death or Orthotopic Liver Transplantation (OLT)).

resultsIn total of 110 cirrhotic patients (93 males, mean age 50 ± 11 years), the most frequent etiology was alcohol (48%), followed by nonalcoholic steatohepatitis/cryptogenic (26%), hepatitis B (10%), autoimmune hepatitis (7%), and hepatitis C (6%). The distribution of CTP classes was: 4%, 56%, and 41% in class A, B, and C, respectively. Ascites was the most common decompensation found in 88 patients (80%) followed by HE (14%) and GEVB (6%). At 1-year follow up, transplant free survival was 78%, 2 underwent OLT, 4 developed hepatocellular carcinoma, and 24 died. Cumulative incidence of failure (death or OLT) by type of decompensation after 1 year was: 22% overt ascites, 50% GEVB, 28% UD ascites, 20% HE, and 33% ascites and GEVB concomitant.

conclusionsPatients with UD ascites do not have a negligible mortality rate as compared to overt ascites. Patients with cirrhosis after first decompensation have better transplant free survival with treatment of etiology and complications than previously mentioned in literature.

Indexed as

ACLF, Acute-on-Chronic Liver FailureAIH, Autoimmune HepatitisAPASL, Asian Pacific Association for the Study of the LiverascitesCI, Confidence IntervalGEVB, Gastroesophageal Variceal BleedingGI, GastrointestinalHBV, Hepatitis B VirusHCC, Hepatocellular CarcinomaHCV, Hepatitis C VirusHE, Hepatic Encephalopathyhepatic encephalopathyhepatocellular carcinomaHRS, Hepatorenal Syndromeliver transplantMELD, Model for End-Stage Liver DiseaseNASH, Nonalcoholic SteatohepatitisOLT, Orthotopic Liver TransplantationPPI, Proton Pump InhibitorSAAG, Serum-Ascites Albumin GradientSBP, Spontaneous Bacterial PeritonitissurvivalUD, Ultrasonography

Identifiers

PMID29743797
PMCPMC5938527
OpenAlexW2626080937

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.